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It is widely recognized that exposure to combinations or mixtures of chemicals may result in
highly exaggerated toxicity even though individual chemicals might not be toxic at low doses.
Chemical mixtures may also cause additive or less than additive toxicity. From the perspective of
public health, highly exaggerated toxicity is of significant concern. Assessment of risk from
exposure to chemical mixtures requires knowledge of the underlying mechanisms. Previous
studies from this laboratory have shown that nontoxic doses of chlordecone (10 ppm, 15 days)
and carbon tetrachloride (CCI4) (100 pl/kg) interact at the biologic interface, resulting in potentiated
liver injury and 67-fold amplification of CCI4 lethality. In contrast, although interaction between
phenobarbital and CCI4 leads to even higher injury, animal survival is unaffected because of highly
stimulated compensatory tissue repair. A wide variety of additional experimental evidence
confirms the central role of stimulated tissue repair as a decisive determinant of the final
outcome of liver injury inflicted by hepatotoxicants. These findings led us to propose a two-stage
model of toxicity. In this model, tissue injury is inflicted in stage one by the well-described
mechanisms of toxicity, whereas in stage two the ultimate toxic outcome is determined by
whether timely and sufficient tissue repair response accompanies this injury. In an attempt to
validate this model, dose-response relationships for injury and tissue repair as opposing
responses have been developed for model hepatotoxicants. Results of these studies suggest
that tissue repair increases in a dose-dependent manner, restraining injury up to a threshold dose,
whereupon it is inhibited, allowing an unrestrained progression of injury. These findings indicate
that tissue repair is a quantifiable response to toxic injury and that inclusion of this response in
risk assessment may help in fine-tuning prediction of toxicity outcomes. Environ Health
Perspect 1 06(Suppl 6):1307-1317 (1998). http://ehpnetl.niehs.nih.gov/docs/1998/Suppl-6/
1307-1317soni/abstract.html
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People are concurrently or subsequently
exposed to a range of toxic substances, and
public concern regarding the adverse health
effects ofexposure to mixtures ofchemicals
has increased. These realities have height-
ened the need for exposure assessment,
hazard identification, and risk characteriza-
tion ofchemical mixtures. Generally, safety
evaluation of exposure to chemicals is
based on studies of single individual
chemicals. The large number of chemicals
and their permutations and combinations
dictates that mechanistic studies be con-
ducted in a carefully designed research pro-
gram to develop strategies to protect public
health. From a perspective ofpublic health,
a major toxicologic issue is the possibility
of unusual toxicity due to interaction of
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two or more toxic chemicals at individually
harmless levels with environmental or
occupational exposures.
In classic chemically induced toxicity
studies only toxic injury has been measured
as the end point of the mechanisms that
inflict injury. In addition to toxic response,
however, tissue repair, a simultaneous bio-
logic compensatory response that accompa-
nies chemical-induced injury, also needs
due consideration (1,2). Several studies
suggest that the rate and extent of tissue
repair as a response to the injury inflicted
by toxicants determines the ultimate out-
come ofhepatotoxicity (3-21). Blockage of
the tissue repair leads to progression of
injury, culminating in hepatic failure and
death (9-16). Because stimulation oftissue
repair is a biologic response that accompa-
nies injury, quantifying this response in
addition to measuring injury might be
helpful in predictive toxicology.
PreviousStudies
Earlier studies that form the basis of our
present investigation indicated that tissue
repair plays an important role in the
progression of toxicity [see reviews by
Mehendale (1,2)]. Prior exposure to a
nontoxic level ofchlordecone (10 ppm for
15 days) results in a marked amplification
of carbon tetrachloride (CC14) hepato-
toxicity and lethality. Neither the close
structural analogs ofchlordecone, mirex,
and photomirex nor phenobarbital exhibit
this propensity for increased lethality.
Chlordecone also potentiates the hepato-
toxicity and lethality of chloroform
(CHC13) and bromnotrichloromethane
(BrCCl3). Although the toxicity of these
closely related halomethanes is potentiated
by such low levels ofchlordecone, the toxi-
city ofstructurally and mechanistically dis-
similar compounds like trichloroethylene
and bromobenzene is not potentiated. This
remarkable capacity to potentiate halo-
methane hepatotoxicity is not related to
chlordecone-induced cytochrome P450 or
associated enzymes, enhanced bioactivation
of CC14, increased lipid peroxidation, or
decreased glutathione. These and other can-
didate mechanisms were considered care-
fully in experiments designed to verify their
adequacy and were found inadequate; addi-
tional experiments revealed that tissue repair
plays an important role in the progression of
toxicity (2).
Further studies designed to investigate
the underlying mechanisms demonstrated
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that ordinarily a low dose ofhalomethane
such as CC14 is not lethal because ofthe
stimulated cell division and tissue repair that
occurs simultaneous to the infliction ofliver
injury (17,18). Subsequent studies revealed
that the recovery from injury inflicted by a
low dose ofCC14, CHC13, or BrCCl3 is due
to the stimulation of cell division that
occurs in two phases (1,2,17-21). First, a
burst ofcell division occurs as early as 6 hr
after CC14 administration with a second
larger wave ofcell division occurring 36 to
48 hr after the administration ofCC14. It
is clear that the early burst ofcell division
is due to the mobilization ofa small num-
ber ofhepatocytes that are normally pre-
sent in the liver in G2 phase (6,7). During
chlordecone + CC4 interactive toxicity
abolishment in the early phase ofcell divi-
sion was observed. A number ofproinflam-
matory cytokines (tumor necrosis factor
alpha, interleukin-6), growth factors (epi-
dermal growth factor, transforming growth
factor alpha [TGF-ax], hepatocyte growth
factor), and protooncogenes (c-myc, c-jun,
H-ras) are overexpressed during cell divi-
sion, and these products ofgene expression
facilitate division ofother cells in the tissue
(22-25). Ifthe early phase ofcell division
does not occur, the mechanisms and signals
necessary to facilitate the neighboring cells
would not occur, thereby preventing ade-
quate second-phase cell division and result-
ing in progression of injury and animal
death. By 44 to 36 hr, although the second
phase ofcell division does occur, in the face
ofunrestrained progression ofinjury this
cell division and tissue repair comes too lit-
tle and too late to restrain the accelerated
progression ofinjury (1,2,17,21).
CellularBankruptcyinAdenosine
Triphosphate Leads toFailure
in TssueRepair
In chlordecone+CC14 combination treat-
ment, low levels of hepatic adenosine
triphosphate (ATP), a consequence ofpre-
cipitous glycogen depletion triggered by
Ca2+ flooding, may be the reason for fail-
ure of hepatocytes to divide (26-28).
Depletion ofATP appears to be due to the
stress ofcellular injury and Ca2+ extrusion
through ATP-driven Ca2+ pumps. Studies
designed to investigate the role ofhepatic
energy status using fructose 1,6-diphos-
phate or ATP as an externally supple-
mented source ofenergy have provided
evidence consistent with the energy hypoth-
esis (29-31). Further studies designed to
test the validity of this concept using
cyanidanol, a compound that increases
hepatic ATP levels, revealed significant
protection (32,33). A time-course study of
the biochemical and histomorphometric
analysis ofcell proliferative activity indi-
cates that the hepatoprotective action of
cyanidanol is not due to mitigation ofthe
early events leading to liver injury. The
findings are more consistent with cyani-
danol mobilizing the cellular biochemistry
to stimulate the S-phase of the cell cycle
through the availability ofATP. In the
presence ofhepatotoxic stimulus repre-
sented by hepatocellular necrosis, the cells
in S-phase divide, providing new cells for
hepatolobular restoration, tissue healing,
and recovery from injury. From these
studies it seems reasonable to assume that
the decrease in normal physiologic concen-
trations ofATP in the hepatocytes critically
affects tissue repair and the restoration of
hepatolobular architecture. Studies with
direct administration ofATP to rats under-
going chlordecone+CC14 toxicity also sup-
ported this concept. Injection ofATP to
chlordecone-pretreated rats at -1, +1, 3, 5,
12, 24, and 36 hr of CC14 injection
resulted in 100% survival (31). A signifi-
cant protection was observed in markers of
liver toxicity. Further studies were designed
to investigate the possibility ofdecreased
metabolism ofCC14 during ATP protec-
tion. Regardless ofATP intervention,
approximately 75% of the administered
' CC14 was expired as unmetabolized CC14
within 6 hr in rats treated with the
chlordecone + CC14 combination (31).
Interestingly, the in vivo metabolism of
14CC14, as evidenced by 14C02 expiration,
was significantly increased in chlordecone+
CCl4-treated rats receiving ATP. An
increase in CC14 metabolism instead ofthe
anticipated decrease indicates that the ATP
protection cannot be attributed to the
diminished bioactivation ofCC14 (31).
These findings suggest that ATP adminis-
tration during the early phase of injury
restores normal liver function and tissue-
healing mechanisms, permitting restoration
ofhepatolobular structure and function
and animal survival.
In contrast to these observations,
exposure to higher levels ofphenobarbital
but the same low level ofCC14 results in
almost twice as much liver injury but does
not lead to increased animal mortality
(34,35). Depletion ofATP does not occur
in these livers (26,27). Therefore, the only
consequence of this highly toxic liver
injury is to postpone the early phase cell
division until 24 hr but not abolish it. The
second phase of cell division is greatly
stimulated (26). In combination, this wave
ofhighly stimulated cell division and tissue
repair leads to systematic restoration of
hepatolobular structure and function,
followedbyfull animal recovery.
ATwo-Stage Model
ofToxicity
The previously described studies led to the
proposal of a two-stage model ofhepato-
toxicity. An intriguing aspect ofthis work
with toxicologic interactions and effects on
tissue repair and injury is the emergence of
a concept thatpermits theseparation ofthe
initial events responsible for infliction of
injury from subsequent events that deter-
mine the final outcome of that injury
(Figure 1). Hormetic mechanisms are acti-
vated upon exposure to toxicants.Although
the mechanisms responsible for triggering
mobilization ofbiochemical events leading
to cellular proliferation after the adminis-
tration of a toxicant are not fully under-
stood, it is clear that early events involved
in tissue repair are the critical determinants
for the final outcome oftoxicity. Studies
described here (1-21,36-40) support the
concept of a two-stage model oftoxicity
(Figure 1). Stage one, the inflictive stage,
comprises mechanisms of initiation of
injury; the second stage determines the
progression/regression ofinjury. The latter
Stage one
Initiation
and infliction
ofinjury
Recovery
Stage two
Progression
and massive
injury
Chemical - Cellular injury Suppressed
Intoxication tissue repair
mechanisms
Figure 1. Scheme illustrating the proposed two-stage
model oftoxicity. Stage one involves infliction of cellu-
lar and/or tissue injury by intoxication mechanisms,
which are well established for many chemical and
physical agents. When injury is inflicted by a low dose
of the offending agent (stage one), hormetic mecha-
nisms such as cellular regeneration and tissue repair
targeted for restoration of tissue structure are stimu-
lated and complete recovery from injury follows with
no additional consequence. If hormetic mechanisms
are suppressed or ablated, the limited injury associ-
ated with exposure to a low dose of the offending
toxic agent would continue unabated, resulting in pro-
gressive injury. High doses of toxic agents can cause
ablation of stimulated tissue repair.
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stage involves biologic response mechanisms
of cell division and tissue repair initiated
by a cascade of toxicodynamic events.
These response mechanisms lead to
restrained injury and full recovery from
low to moderate doses of toxicants. It
appears that irrespective ofthe mechanism
of infliction of liver injury in the first
stage, the ultimate outcome ofhepatotoxic-
ity, i.e., progression or regression of injury,
depends on the timely and adequate
appearance oftissue repair mechanisms.
Injury and Tissue Repair Are
Opposing Toxicodynamic
Forces in Predictive
Toxicology ofChemicals
The characteristics ofexposure to noxious
agents and the spectrum of toxic effects
come together in a correlative relationship,
customarily referred to as the dose-response
relationship, the most fundamental and
pervasive concept oftoxicology. This con-
cept is used in predictive toxicology and
consequently is a basic principle used in risk
assessment. In developing dose-response
relationships for toxic chemicals, at present
only toxic injury is measured against a
series ofincreasing doses. This information
is incomplete and leads to erroneous pre-
dictions because it does not take into con-
sideration the opposing and dynamic
reparative and tissue restoration response.
The above-described studies suggest that
injury and tissue repair are simultaneous
but opposing parallel responses to adminis-
tration oftoxic chemicals. Ifstimulated cell
division and tissue repair are critical in pre-
dicting the ultimate outcome of toxic
injury, then in addition to measuring
injury in response to increasing doses of
chemicals, it would be advantageous to
measure the simultaneous but opposing
response of stimulated tissue repair. This
new dose-response paradigm would be
more precise and accurate in predicting the
final outcome oftoxic injury.
Inclusion of tissue repair stimulation as
the biologic event opposing injury may
result in two sets ofdose-response curves
in the classic dose-response paradigm
(Figure 2). At lower doses, as injury begins,
a simultaneous but opposing tissue repair
response appears, allowing the animals to
overcome that injury. Predictably, these
animals will suffer from injury but are res-
cued from progression ofinjury and death.
As the dose increases, a threshold is reached
where any additional increment in the dose
will result in two adverse effects. First,
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Figure 2. A typical dose-response relationship
between the two opposing forces of inflicted injury and
stimulated tissue repair upon exposure to a toxic
chemical. As the dose increases, tissue repair is
increased, allowing recovery from tissue injury. When
the dose exceeds the threshold, tissue repair is attenu-
ated and delayed, allowing injury to progress in an
unrestrained manner and leading to organ or tissue
failure and animal death. Quantifying both injury and
adverse effect as well as stimulated tissue repair
simultaneously as a dose-response relationship
might be helpful in assessing the outcome of the inter-
action between these two opposing forces. The
dose-response relationship can be used to explain
interindividual differences, just as it can be used to
explain differences among populations.
stimulation of tissue repair, which seems
to be delayed with each incremental dose,
is now much too delayed. Second, the
amplitude of the tissue repair response is
diminished. Therefore, decreased stimu-
lation of tissue repair will result in unre-
strained progression of injury and animal
death. In addition to the use of the
dose-response curve for prediction of the
ultimate outcome in individual subjects,
such a response can also be used for pre-
diction in a population. To test this con-
cept, we conducted studies with model
hepatotoxicants (8,41-43).
Dose-Response Studies
withThioacetamide
The purpose ofthis study was to establish a
dose-response relationship for thioac-
etamide, where tissue injury and repair
were two simultaneous but opposing
dynamic responses (8). Rats were injected
with a 12-fold dose range ofthioacetamide
(50, 150, 300, and 600 mg/kg) and both
liver injury and tissue repair were measured
over a time course. Liver injury was assessed
by serum enzyme elevations and by
histopathology. Serum alanine aminotrans-
ferase (ALT) elevation did not show any
dose response over a 12-fold dose range up
to 24 hr (Figure 3A). A dramatic elevation
in ALT was evident after 48 hr and only
for the highest dose. Tissue regeneration
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Figure 3. Dose response for liver injury and tissue
repair after thioacetamide administration to rats. Male
S-D rats were divided into four groups. At time zero,
groups received ip injection of 50, 150, 300, and 600
mg/kg thioacetamide. Controls received normal saline.
(A) Plasma ALT measured as a marker of liver injury.
(8) [3H]-thymidine incorporation into hepatocellular
nuclear DNA measured as a marker of hepatocellular
regeneration. Data adapted from Mangipudy et al. (8).
response was measured by [3H]-thymidine
incorporation into hepatocellular DNA
and by proliferating nuclear cell antigen
(PCNA) procedure during a time course
(6, 12, 24, 36, 48, 72, and 96 hr). Tissue
regeneration, as indicated by [3H]-thymi-
dine incorporation in DNA, peaked at 36
hr after administration of a low dose of
thioacetamide (50 mg/kg). With increasing
doses, a greater but delayed stimulation of
cell division was observed until a threshold
(300 mg/kg) was reached. With a further
increase (600 mg/kg) above the threshold
dose, tissue repair was substantially delayed
and diminished (Figure 3B), and injury as
assessed by ALT elevations was remarkably
accelerated, indicating unrestrained pro-
gression of injury leading to animal death.
These findings suggest that, in addition to
the magnitude ofthe tissue repair response,
the time at which this occurs is critical in
restraining the progression of injury,
thereby determining the ultimate outcome
oftoxicity.
Dose-ResponseStudies
with CarbonTetrachloride
Similar studies were conducted with a
40-fold dose range ofCC14 (41). The find-
ings of this study were similar to those of
thioacetamide described above. The dose
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ranges used for the CC14 study were 0.1, 1,
2, 3, and 4 ml/kg (ip). Rats receiving 4
ml/kg CC14 (ip) experienced 80% mortal-
ity within 2 days. It was routinely observed
that 20% of the animals consistently sur-
vived this dose. Examination of [3H]-
thymidine incorporation in the 20% group
surviving at 48 hr revealed a massive
increase (5-fold) in S-phase synthesis at this
time point; the increase was sustained until
72 hr. These findings were corroborated by
PCNA studies, which revealed a commen-
surate increase in the number ofcells pro-
gressing through the cell division cycle as
compared to the lower doses. This timely
and highly stimulated tissue repair restrains
the progression of liver injury due to
replacement of the dead cells by newly
divided resilient cells, resulting in restora-
tion ofthe hepatic lobular structure in this
group ofsurviving rats (41).
Dose-ResponseStudies
with o-Dichlorobenzene
In these studies, male Fischer 344 (F344)
rats were administered different doses of
o-dichlorobenzene (o-DCB) (0.2, 0.6, 1.2
ml/kg, ip). Liver injury, as assessed by
plasma ALT elevation and by histologic
alterations, did not show a dose-dependent
increase. The appearance ofpeak injury was
delayed with an increased dose of o-DCB.
With the lowest dose, injury peaked at 24
hr, whereas with the highest dose the injury
peaked at 60 hr. Liver regeneration, as eval-
uated by [3H]-thymidine and PCNA,
showed dose-dependent increases at the
lower two doses. Increasing the dose further
to 1.2 ml/kg o-DCB resulted in delayed
and diminished tissue repair response (42).
These studies further support the concept
that tissue repair is a function ofdose and
as the dose increases tissue repair increases
only up to a threshold dose. Beyond the
threshold, tissue repair is delayed, which
allows liver injury to progress.
Dose-ResponseStudies
withTrichloroethylene
In these studies rats were treated with a
10-fold dose range of trichloroethylene
(250, 500, 1250, and 2500 mg/kg) and
hepatotoxicity and tissue repair were stud-
ied over a time course of0 to 96 hr (43).
Light microscopic changes in hematoxylin-
eosin-stained liver sections revealed a dose-
dependent incidence of hepatic necrosis.
However, liver injury as assessed by plasma
sorbitol dehydrogenase (SDH) showed a
dose-response over a 10-fold dose range
only at 6 hr, whereas ALT did not show a
dose response at any of the time points
studied. Further studies designed to inves-
tigate the discrepancy between plasma
enzymes and histopathology indicated that
the lack of dose-related increase in SDH
and ALT activities may be because of the
inhibition of these enzymes by trichloro-
acetic acid, a metabolite of trichloro-
ethylene. Tissue regeneration response as
measured by [3H]-thymidine incorporation
was stimulated maximally at 24 hr after
500 mg/kg trichloroethylene administra-
tion. Higher doses oftrichloroethylene led
to a delay and diminishment in [3H]-
thymidine incorporation. These results
further support the concept ofdose-related
increase in tissue repair up to a threshold
dose and inhibition oftissue repair at doses
above this threshold, leading to organ failure
and animal death.
DoseResponseRelationships
forInjuryandTissueRepair
Afascinating outcome ofthese dose-response
studies is the dynamic relationship between
the tissue repair response and the progres-
sion of the injury. Accelerated progression
of liver injury becomes evident only after
failure to elicit a prompt tissue repair
response that culminates in liver failure
and death. In all the previous examples tis-
sue repair due to high dose is delayed and
attenuated. Thus, a failure in timely and
adequate appearance of tissue repair leads
to an unrestrained progression of injury in
high-dose treated groups. Approaches pro-
posed in the literature to date for describ-
ing the dose-response relationship for
cytotoxic chemicals such as chloroform
have implicitly assumed that injury as
measured by cell death or enzyme leakage
is coupled in a one-to-one relationship
with repair, as measured by cell division
(44-46). However, the true functional
relationship can be investigated by the
application of statistical methods to test
various hypotheses regarding the temporal
and causative interactions between injury
and repair. This dynamic interplay can be
stated in a biologically based empirical
mathematical model:
Outcome=f(repair, injury)
Outcome=f{repair(t) -injury(t)}dt
Outcome=f{repair(t) x W,(t)
-injury(t)x Wi(t)}dt
where W'(t) is the weight given to repair
(cell division), Wi(t) is the weight given to
injury (cell death). Based on our preliminary
experiments, we suggest that for a given
dose the ultimate outcome of injury is a
function of the net difference between
repair and injury and that this difference
can be integrated. This model may provide
greater precision in risk assessment because
this model is biologically based and it takes
into account the dynamic nature of tissue
repair and tissue-healing processes. If
experimentally validated, this concept
might be more useful in improving the
current paradigms ofpredictive toxicology
and the science behind it.
Role of Stimulated Tissue
Repair in Auto- and
Heteroprotection Models
Stimulated cell division and tissue repair by
exposure to toxicants has several implica-
tions. Clearly, the newly divided cells are
available to restore tissue structure and
function (1,2). A second aspect ofthis phe-
nomenon appears to be the extra resiliency
that comes with newly divided cells. Several
investigators have reported that newly
divided cells are resistant to the toxic action
ofa variety ofchemicals (47-55). It appears
that this mechanism may work to restrain
the progression of injury in a tissue where
cell division and tissue repair are permitted
to occur. These concepts have been tested
in auto- and heteroprotection models.
Autoprotection
If stimulated tissue repair is critical for
animal survival upon administration of a
toxic chemical at a lethal dose, one should
be able to protect animals from the lethal
action of an ordinarily lethal dose by
stimulating tissue repair in advance by pre-
exposure to a low dose of the same com-
pound. Studies have revealed that CC14
autoprotection is due to the stimulation of
cell division and tissue repair induced by
preexposure to a low dose ofCC14 admin-
istered 24 hr prior to the administration of
the lethal dose (10-13). In a similar fash-
ion, thioacetamide autoprotection is also
due to the preplacement of tissue repair
stimulated by a low dose of thioacetamide
(15). Antimitotic intervention with the
stimulation of tissue repair by colchicine
leads to abolition ofautoprotection in both
the models (9,11). In the experiments with
CC14, neither bioactivation nor the disposi-
tion ofCCl4 were affected (11,12). Expo-
sure to phenobarbital postpones the early
phase ofcell division to 24 hr (47). Ifstim-
ulated cell division is the primary mecha-
nism responsible for CC4 autoprotection,
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administration of the priming dose in
phenobarbital-induced animals should lead
to postponement ofmaximal autoprotection
by approximately 24 hr. Autoprotection
experiments with phenobarbital-induced
animal models revealed that maximal auto-
protection was delayed by 24 hr in com-
parison to autoprotection in naive animals
(47). These experiments also revealed that
destruction of cytochrome P450 by the
priming dose ofCC14 was not the primary
mechanism ofautoprotection. The discov-
ery ofstimulated tissue repair as the under-
lying mechanism ofCC14 autoprotection
has far-reaching implications for the toxi-
cology of chemical combinations and
chemical mixtures.
Heteroprotection
The experiments previously described
suggest the possibility ofprotecting animals
from a lethal dose ofa compound by pre-
placing stimulated tissue repair in animals
using any toxic chemical. Studies in which
a low dose of thioacetamide was used to
preplace stimulation ofcell division have
confirmed this concept, adding additional
evidence in support ofthe key role oftissue
repair in ultimate toxic outcome regardless
of the extent of injury. Rats receiving a
lethal dose ofacetaminophen 36 hr after
administration of thioacetamide (50
mg/kg) are fully protected from aceta-
minophen-induced lethality (48). Detailed
studies revealed that neither the disposition
of acetaminophen nor the bioactivation
and infliction of acetaminophen liver
injury are affected by prior treatment with
thioacetamide. Preplaced stimulated tissue
repair appears to sustain continued tissue
repair, restrain acetaminophen-induced
liver injury from progression, and enable
the animals to recover from the normally
lethal injury ofacetaminophen (48).
ResistanceofNewlyFormed
Cells toToxicity
Because of the complex makeup of the
liver, designing definitive experiments to
test whether and how much the resiliency
ofnewly divided cells contributes to recov-
ery from toxic injury presents formidable
difficulties. Therefore, this concept was
tested in a simpler extrahepatic tissue
model. To test the role oftissue repair and
newly formed cells, studies were conducted
with 2-butoxyethanol (2-BE), a glycol ether.
These studies have led to greater insights in
this regard (50,51). When given at toxic
doses, 2-BE causes massive hemolysis, which
leads to secondary toxic effects ultimately
resulting in animal mortality. Prior repeated
exposure to low levels ofthis chemical was
reported to cause tolerance against 2-BE-
induced hemolysis (56). Based on this
concept an autoprotection model of2-BE
was established (50,51). Animals receiv-
ing one single moderately toxic dose of2-
BE experience an episode of hemolysis
but are able to survive. During the follow-
ing 7 days, animals replace all of the lost
red blood cells through erythropoietic
stimulation to restore their original hema-
tocrit. At this point, when the animals are
challenged with a lethal dose of 2-BE all
the animals survive. The underlying
mechanism was the resilience of newly
formed red blood cells to hemolysis
(Figure 4). The possibility that the sur-
vival afforded by prior exposure to a mod-
erately toxic dose of 2-BE against a
subsequent lethal challenge of the same
compound could be due to the resilience
of newly formed red blood cells was fur-
ther tested. If newly divided cells are
indeed the mechanism behind animal sur-
vival, protection should also be observed
in animals that are bled and allowed to
recover. Indeed, experiments in which the
animals were bled to attain the same level
ofhematocrit obtained with a moderately
toxic 2-BE-induced hemolytic episode
confirmed that the mechanism behind
this autoprotection was indeed due to
newly formed red blood cells (Figure 4)
(51). These findings have been pivotal in
gaining new insights into biologic events
that restrain injury.
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Figure 4. Resistance of newly formed red blood cells
to 2-butoxyethanol hematotoxicity in animals; survival
profile following lethal challenge with 2-butoxyethanol
(1500 mg/kg). Rats were bled 2.5 mI/day for 3 days
under light diethyl ether anesthesia. Blood-letting was
followed by a 7-day period of recovery. Recovery was
ensured by a return of depleted hematocrit values to
prebled levels. Both bled and recovered rats as well as
their sham-treated controls were challenged with a
lethal dose of 2-BE and their survival was recorded.
Data adapted from Cai and Mehendale(49).
Factors Affecting
Tissue Repair
In addition to the dose of a chemical,
several other factors affect the magnitude of
tissue repair on toxicant exposure. Among
these factors are some associated with the
chemical characteristics of the toxicant.
Others are associated with the host animal
exposed to these toxic chemicals. Studies on
species/strain differences, nutritional status,
and age ofthe animal also emphasize the
roleplayedbythese factors.
Speces andStrainDifferences
inTueRepair
Species and strain differences in response to
toxicant exposure are widely reported in the
literature. Enormous differences in the
extent to which tissue repair is stimulated
have been observed between different
species (42,57-59). For example, the 35-
fold higher sensitivity ofgerbils to CC14 in
comparison to rats is due to sluggish tissue
repair in gerbils (58). Substantial delay in
the stimulation of tissue repair in gerbils
results in unrestrained progression ofeven
limited liver injury in this species. The
bioactivation ofCC14 in gerbils is approxi-
mately three times higher than in the rat
(57), which translates into a higher inflic-
tion of injury in gerbils to begin with.
However, increased infliction ofliver injury
in the gerbil as a result ofhigher bioactiva-
tion only partially explains the markedly
higher sensitivity of this species to CC4
(57-59). Two lines ofevidence are avail-
able to suggest that higher bioactivation
only partially explains this high sensitivity.
First, ifgerbils are subjected to partial hepa-
tectomy intended to stimulate tissue repair
processes, bioactivation of subsequently
administered CC14 is not diminished (58).
However, survival ofthe partially hepatec-
tomized gerbils from ordinarily lethal doses
ofCC14 suggests the critical role played by
preplaced tissue repair on animal survival.
Secondly, administration ofdrug-metabo-
lizing enzyme inducers such as phenobarbi-
tal and mirex, which induce the isozyme
responsible for bioactivation of CC14,
results in an additional 2-fold increase in
bioactivation (59). However, this does not
lead to increased lethality in the gerbil.
Although this has not been specifically
investigated in gerbils, survival of the ani-
mals in spite of increased liver injury by
prior exposure to phenobarbital may be
related to increased tissue repair response,
as was the case in rats (47,59).
F344 rats have been reported to be
75-fold more sensitive than Sprague-Dawley
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rats (S-D rats) to liver injury of o-DCB
(60,61). Whether this difference in liver
injury is reflected in ultimate toxic out-
come (survival/lethality) was not known.
Studies revealed that the median lethal
dose of o-DCB did not differ between
F344 and S-D rats (42). In contrast to the
reported 75-fold higher liver injury, we
found only 10- to 15-fold higher injury in
F344 rats compared to S-D rats (60,61).
Lethality studies suggested that even
though higher liver injury was evident in
the F344 rats, this did not lead these ani-
mals to experience any higher mortality.
Tissue repair stimulated in response to dif-
ferent doses of o-DCB (6-fold dose range)
was compared between these two strains.
These studies indicated that tissue repair
response in the F344 rat is approximately 4
to 10 times higher than the S-D rat, sug-
gesting that higher injury in F344 rat livers
is of no consequence to animal survival
because an exacting level of tissue repair
stimulation rescues these animals (42).
Similar to these studies, marked differences
in CC14 toxicity among four strains ofmice
have been reported to be due to differential
tissue repair (62,63).
These examples of species and strain
differences also illustrate yet another
important point. In animal-to-animal and
animal-to-human extrapolation of toxicol-
ogy data, uncertainty factors are often used
because the mechanisms responsible for
strain and species differences are not
known. Risk assessors have relied largely on
arbitrary uncertainty factors to take a more
conservative and safer approach. It is
becoming increasingly clear that a more
scientific and rational approach might be
to consider the two stages of toxicity in
interstrain and interspecies extrapolation.
We know relatively more about the differ-
ences in mechanisms responsible for inflict-
ing injury amongstrains and species. Much
less is known about the biologic toxico-
dynamic events that follow injury. In the
absence of information regarding the
mechanisms underlying species differences,
we have often relied solely on the differ-
ences in bioactivation mechanisms as indi-
cators ofspecies differences. However, the
previous two examples illustrate that the
sole use of differences in bioactivation
mechanisms as the basis for interspecies
extrapolation cannot bejustified.
Nutritional Status andTissue Repair
Role ofGlucose. Nutritional status is
another host-related factor that signifi-
cantly impacts tissue repair response.
Carbohydrate substrates such as glucose are
readily available sources of energy exten-
sively used in emergency medicine. Some
literature reports have suggested that glu-
cose may inhibit stimulation ofcell divi-
sion and tissue repair (64,65). However,
the impact ofglucose as a source ofenergy
on toxicant-induced injury and the ulti-
mate outcome of that injury were not
investigated. In recent studies the effect of
glucose loading on thioacetamide hepato-
toxic injury and lethality was examined
(37,66). It was hypothesized that glucose
loading would lead to higher lethality of
thioacetamide. A hepatotoxic dose of
thioacetamide (300 mg/kg) that is free
from any toxicant-induced mortality was
used in these studies. Although none ofthe
glucose-loaded rats survived this dose of
thioacetamide, all animals without glucose
loading survived. Subsequent investigations
revealed that glucose loading results in
70% inhibition ofcell division stimulated
by thioacetamide (37,66). In addition
to thioacetamide, glucose loading also
increased the mortality of CC14, CHCl3,
and acetaminophen, suggesting that this
effect is not related to chemical structure or
mechanism ofinfliction ofinjury (37,67).
Role ofPalmitic Acid. In another set
of experiments using thioacetamide as a
model hepatotoxicant to inflict centrilobu-
lar injury, the diet of rats was supple-
mented with 8% palmitic acid (equicaloric
with 15% glucose experiments) to investi-
gate if supplemental fatty acids would
enable these animals to survive a lethal
dose of thioacetamide (66-68). Rats
administered a 600-mg/kg dose of thioac-
etamide ordinarily fail to survive. All ofthe
rats maintained on the fatty acid-supple-
mented diet survived even though they had
been injected with a lethal dose (600
mg/kg) ofthioacetamide. Additional inves-
tigations revealed that fatty acid-supple-
mented animals are able to mount a 70%
higher cell division and tissue repair over
the controls not receiving palmitic acid
supplementation (68).
The above findings suggest that alter-
ations in macronutrients such as glucose
and fatty acids have a rather decisive and
significant impact on the outcome ofhepa-
totoxic injury. It should be noted that
bioactivation mechanisms were not com-
promised in either of these two examples
(37,68). Indeed, in the fatty acid-supple-
mented rats, bioactivation ofthioacetamide
was increased, which led to a correspond-
ing level ofincreased liver injury (68). In
spite of the increased injury, the animals
were able to overcome this injury because of
remarkably stimulated tissue repair proc-
esses. Thesefindings suggest that nutritional
differences in human diet are likely to
contribute substantially to interindividual
differences intoxicity (66).
Further studies were conducted to
investigate the molecular mechanisms
responsible for increased cell division after
thioacetamide administration to rats
fed the fatty acid-supplemented diet.
Protooncogene expression plays an impor-
tant role in stimulation ofcellular prolifer-
ation during tissue regeneration. Liver
regeneration is accompanied by a dramatic
early increase in the expression of c-myc
and other protooncogenes, which precedes
the onset ofincreased DNAsynthesisby at
least 20 hr (66,67). Blockage of c-myc
expression by indomethacin or decadron
following partial hepatectomy impedes
liver regeneration, suggesting the necessity
of c-mycexpression for the stimulation of
DNA synthesis and cellular proliferation
(66). A higher expression of c-myc was
seen 48 hr after thioacetamide administra-
tion but not at 24 and 36 hr in the livers
of rats fed a fatty acid-supplemented diet
as compared to rats fed a normal diet. A
higher c-mycexpression at 48 hr in rats fed
afattyacid-supplemented diet is consistent
with the observed higher S-phase synthesis
rate in these rats at 72 hr as compared to
rats on a normal diet. Higher expression of
p53 started at 6 hr in rats on a fatty acid-
supplemented diet, but at 36 hr both the
groups had similar expression. At 48 hr
the expression ofp53 was lower in rats on
a fatty acid diet as compared to rats fed a
normal diet. Presumably, a higher expres-
sion of the p53 tumor-suppressor gene
helps inhibit cell division, which took
place at 72 hr in the rats without fatty
acid supplementation. Expression of the
H-ras was same in both the groups,
suggesting the probability of a minimal
role played by this protooncogene in
the protection provided by fatty acid
supplementation against thioacetamide
hepatotoxicity. Although definitive con-
clusions regarding the specific roles for
expression of these protooncogenes await
additional studies, these findings suggest
that cause-effect relationships between
protooncogene expression on the toxic
outcome ofhepatotoxicity are likely.
Role of Diet Restriction. The
previously described studies suggest that
xenobiotic-induced tissue repair is depen-
dent on the source of cellular energy.
Moderate diet restriction significantly
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increases maximum and mean life span and
prevents, delays, or retards the incidence
of a plethora of age-associated diseases
(69). More recently, the effect of moder-
ate diet restriction on hepatotoxicity of
thioacetamide has been investigated
(70-72). Male rats were maintained on
65% oftheir adlibitum food consumption
for a period of 3 weeks and then treated
with a single low dose of thioacetamide
(50 mg/kg). Maximal liver injury occurred
in diet-restricted rats and was 6-fold
greater than that observed in the group fed
ad libitum. Histopathologic examination
of the liver sections revealed liver injury
concordant with plasma enzyme eleva-
tions. Interestingly, there was a higher and
sustained S-phase stimulation in the diet-
restricted rats as compared to the group
fed ad libitum. PCNA studies revealed a
corresponding stimulation of cell-cycle
progression, indicating highly stimulated
compensatory tissue repair. Although there
was increase in injury, lethality experi-
ments (600 mg/kg thioacetamide) indi-
cated 70% survival in the diet-restricted
group as compared to 10% survival in the
ad libitum group. These findings suggest
that although diet restriction increases
hepatotoxic injury of thioacetamide, it
protects from the lethal outcome by
enhanced liver tissue repair. Because these
findings raise the possibility that higher
repair may be the result ofhigher injury, a
study was undertaken with an equitoxic
dose ofthioacetamide.
Preliminary studies revealed that 600
mg/kg thioacetamide in rats fed adlibitum
was equitoxic to 50 mg/kg thioacetamide
in diet-restricted rats (71,72). At 12 and
36 hr the liver injury was almost equal in
both the groups. A prompt and enhanced
tissue repair response in diet-restricted rats
at the low dose (6-fold higher liver injury)
occurred, whereas at equitoxic dose (600
mg/kg), tissue repair in rats fed adlibitum
was substantially diminished and delayed.
The extent ofliver injury was not closely
related to the extent ofstimulated tissue
repair response. Light microscopy of liver
sections revealed progression of hepatic
injury in rats fed ad libitum, whereas by
120 hr injury regressed completely, leading
to recovery in diet-restricted rats. Diet
restriction resulted in abolition ofthe delay
in tissue repair associated with the lethal
dose of thioacetamide in rats fed ad
libitum. This reversal ofdelay to restore
sustained tissue repair response allows a
significant number ofdiet-restricted rats to
escape the lethal consequence (71,72).
ResiliencyofPostnatally
DevelopingRats
Several studies have demonstrated that
neonate and postnatally developing rats are
resilient to a wide variety of structurally
and mechanistically dissimilar hepatotoxi-
cants such as galactosamine, acetamino-
phen, allyl alcohol, and CC4 (49,73-78).
Most interestingly, young rats survive expo-
sure to the lethal combination ofchlorde-
cone and CC14, which causes 100% lethality
in adult male and female rats (49,76,77). In
a study where postnatally developing (20-
and 45-day), and adult (60-day) male rats
were used, administration of CC14 (100
pll/kg) alone resulted in transient liver injury
regardless of age, as indicated by plasma
enzyme (ALT and SDH) elevations and
histopathologic lesions. In chlordecone pre-
treated rats (10 ppm for 15 days), CC14-
induced toxicity progressed with time,
culminating in 25 and 100% lethality by 72
hr after CC14 in 45- and 60-day rats, respec-
tively, in contrast to regression ofinjury
without any mortality in 20-day rats. [3H]-
thymidine incorporation and PCNA studies
revealed an association between delayed and
diminished DNA synthesis, unrestrained
progression of liver injury, and animal
death. Time-course studies revealed that the
loss of resiliency in the two higher age
groups might be due to inability to repair
injured liver rather than to infliction of
higher injury.
Examination of growth factors and
protooncogene expression revealed a 3-
and 3.5-fold increase in TGF-a and H-ras
mRNA expression, respectively, coincid-
ing with maximal hepatocyte DNA syn-
thesis in 20-day rats fed a normal diet, as
opposed to only 2- and 2.5-fold increases
observed in 60-day rats fed a normal diet,
respectively (77). Increased expression of
c-fos (10-fold) in 20-day rats occurred 1 hr
after CC14 as compared to less than a 2-
fold increase in 60-day rats. These findings
suggest that prompt stimulation of tissue
repair permits efficient recovery from
injury during early postnatal development
ofrats.
Shifting Risk Assessment
Paradigm for Public Health
During the last several decades substantial
progress has been made in developing an
understanding of the mechanisms by
which chemical and physical agents initiate
tissue injury (Figure 5). Once injury is ini-
tiated by these mechanisms oftoxicity, cell
death may occur if the cellular defense
mechanisms are overwhelmed. Ifsufficient
numbers of cells are destroyed, tissue
function is compromised and animal death
occurs. The ultimate toxic outcome lies
within the outer bounds of recovery and
death. Regardless of whether toxicity
occurs from acute, subchronic, or chronic
exposure, and whether it results in malig-
nant or nonmalignant toxicity (all ofwhich
lie within the outer bounds ofrecovery and
death as toxic outcomes), we in the public
health sector are interested in increasing
the possibility of recovery. Facilitation of
recovery from injury and elimination of
death are ideal goals in public health.
Studies summarized here have revealed that
distress signals (cytokines, growth factors,
and other gene products) released during
initiation of injury lead to stimulation of
cell division to provide new cells to replace
dead or dying cells. Stimulation of cell
division is a normal dose-dependent
endogenous response with a threshold that
results in recovery from injury. Beyond the
threshold, tissue repair is inhibited by delay
in onset as well as attenuated response,
which result in unrestrained progression of
injury, organ failure, and death.
Increasing the tissue repair response and
inhibiting the response yield substantial
protection and enhancement of toxic out-
comes, respectively. This basic principle is
supported by a number of examples of
Mechanisms oftoxicity
* Free radical formation
* Reactive intermediate formation
* Lipid peroxidation
* Blockade of endogenous pathways
- - - -Cell death
,
------
+ Recovery
Increased =+ et sIgncralse Tissue repair signals ~ ~ ~ - Death
Figure 5. Mechanisms of toxicity. Once inside the
body, chemicals cause injury by well-established
mechanisms such as free radical formation, reactive
intermediate formation, lipid peroxidation, blocking of
endogenous pathways, etc. However, these mecha-
nisms do not predict whether there will be recovery or
if the injury will progress and lead to lethality.
Progression or regression of injury and lethality
depends on the timeliness and extent of tissue repair
response. If tissue repair is active there will be recov-
ery. If tissue repair is inhibited the injury progresses
and the toxic outcome may be lethality.
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Figure 6. Binary mixture toxicity and the role of tissue repair. The combined action of two chemicals may potenti-
ate or antagonize the injury and this potentiating or antagonizing action of the mixture depends on the stimulation
or inhibition of cell division response. Stimulation of tissue repair speeds up recovery, whereas inhibition of tissue
repair leads to progression of injury and animal death. Models are from references (39,36,14,15,35,3,11,3,9,20,19),
respectively.
binary mixtures (Figure 6). Whenever tissue
repair induced by one chemical is further
enhanced by the binary combination of
chemicals, the toxic outcome is survival. In
contrast, if the tissue repair response is
inhibited by the interactants in a binary
mixture, the ultimate toxic outcome is pre-
dictably animal death (Figure 6). It should
be noted that the extent ofliver injury does
not allow prediction of the ultimate out-
come (38-40,71,72). For example, with the
chlordecone +CC14 combination, although
liver injury is less than 50% of that seen
with phenobarbital + CC14 treatment (38,
40), rats receiving the chlordecone +CC14
combination die ofhepatic failure, whereas
those receiving the phenobarbital + CC14
treatment recover from hepatic injury and
survive. Likewise, although isopropanol
potentiation of CC14 toxicity results in
higher liver injury, it does not lead to
increased lethality (39), in contradiction to
normal expectation based on liver injury.
Furthermore, in diet-restricted rats, in spite
ofhigh liver injury, protection is observed
(71,72). The reason for animal survival is
greatly enhanced tissuerepair (71,72).
Implication for Assessment
of Risk to Public Health
Generally, mechanism-driven inflictions of
toxicity orphysiologic alterations are consid-
ered in risk assessment, but compensatory
tissue repair response to injury has never
been considered. Studies on compensatory
tissue repair response will potentially have a
marked impact on the way we conduct risk
assessment, predictive toxicology, and public
health. Significant advances in the under-
standing of mechanisms by which toxic
chemicals inflict injury enable us to predict
with a degree ofconfidence whether a given
toxic chemical or physical agent will inflict
tissue injury under a given set ofexposure
circumstances or not. However, the finding
that the ultimate outcome ofthat injury is a
result of the toxicodynamic and opposing
interaction between two biologic responses
ofinflicted tissue injury and stimulated tis-
sue repair suggests that a great deal more
understanding ofthe underlying biology is
essential before achieving greater precision
in predictive toxicology and riskassessment.
Ofimmediate relevance in this regard
are two important considerations. First, at
least two levels of threshold doses can be
suggested for toxic chemicals (Figure 1):
One lower threshold dose at which cyto-
protective mechanisms are overwhelmed
and cell necrosis occurs and a second
higher threshold dose above which the
biologic compensatory response of cell
division and tissue repair are compromised
in two distinct ways-a significant latency
in stimulating the tissue repair response
and a significantly attenuated response.
The inevitable combined effect of this
compromise is the unabated progression of
tissue injury, loss of organ function, and
threat to survival.
Implications toTherapeuticStrategies
There is a universal acceptance of the
concept that in stage one of toxicity,
collectively all of the cytoprotective
mechanisms offer a mechanistic basis for
threshold dose above which cellular death
will occur (Figure 1). Our studies reveal
that in stage two oftoxicity, there is also a
tissue-based protective response (tissue
repair) that increases with the dose until a
threshold dose is reached (Figures 1 and 3).
Between the two threshold doses there is a
dose-related incremental biologic compen-
satory mechanism that effectively and
promptly restrains tissue injury, permitting
recovery from toxic injury. Stimulated cell
division and tissue repair are the founda-
tions of the biologic compensatory
response (2,8,41-43). This suggests the
possibility of therapeutic intervention in
overcoming tissue injury regardless ofthe
mechanism or the extent of initial inflic-
tion of that injury. Aside from impacting
on safety and risk assessment based on
molecular end points, these powerful con-
cepts have potential as therapeutic and
safety assessment tools in biomedicine and
public health.
Modulation ofCellDivision Dueto
ChemicalInteractions MayLeadto
DecreasedorIncreasedThreshold
Either ofthe two thresholds is subject to
modulation as a result ofinteractive toxicity,
particularly upon exposure to toxic chemi-
cal mixtures, resulting in decreased or
increased infliction of injury during stage
one. Examples of decreased or increased
infliction ofinjury abound in the scientific
literature. For example, the presence of
drug-metabolizing enzyme inducers (or
activators) or inhibitors can result in
increased or decreased infliction of tissue
injury, respectively, in stage one of toxicity.
The resulting consequences of toxicity
are well known and well described in the
toxicologic literature.
However, the possibility of interactive
interference by other chemical(s) at stage
two of toxicity has not been examined
extensively. Because toxicant-stimulated
tissue repair response is critically involved
in the ultimate outcome oftoxicity, inhibi-
tion or enhancement of tissue repair by
other chemicals may lead to unrestrained
progression of injury and mortality or
arrested progression ofinjury and recovery
from injury and survival, respectively.
Examples of both situations are available
(9-16). In the highly amplified toxicity of
CC14 by chlordecone, tissue repair is
inhibited (1,2), which results in unre-
strained progression ofliver injury leading
to 67-fold amplification of CC14 toxicity
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by chlordecone. In contrast, although prior
exposure to phenobarbital (47) or iso-
propanol (39) leads to highly potentiated
infliction of liver injury, simultaneously
enhanced tissue repair allows the animals
to escape the lethal outcome (39,47). In
diet restriction, highly augmented inflic-
tion of liver injury (6-fold higher) is of no
consequence to animal survival because
suitably augmented compensatory tissue
repair is adequate to overcome liver injury
(70-72). These findings suggest that even
though massive (and ordinarily lethal)
injury may occur because ofmodulation of
stage one, enhanced tissue repair in stage
two can compensate, thereby allowing the
reversal of injury. Antimitotic intervention
of cell division by colchicine administra-
tion after the mechanistic processes of
infliction ofinjury (stage one) leads to pro-
gression ofeven limited injury culminating
in lethal outcome from ordinarily non-
lethal doses ofhepatotoxicants (9,11,79).
In summary, the examples described
here serve to illustrate the possibility that
exposure to chemical mixtures may result in
highly amplified lethal outcome, escape
from anticipated increase in lethality, or sig-
nificantly decreased injury. Currently, we
are unable to predict whether and which
chemical components ofa chemical mixture
may inhibit or enhance tissue repair and
under what circumstances effects may occur.
However, studies described here indicate the
possibility that the threshold for lethal out-
come may be lowered when one or more
components of a chemical mixture inhibit
cell division and tissue repair. Likewise, an
increased threshold for lethal outcome is
possible when one or more components of
the chemical mixtures enhances the cell
division and tissue repair. The third possi-
bility is that no component in the chemical
mixture may significantly modify tissue
repair. Future effort should be directed
toward identifying these possibilities using
defined binary, ternary, and quaternary
mixtures as model organic toxicants.
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